INSYS Therapeutics, Inc. (INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the appointment of Elizabeth Bohlen as a new independent member of its Board of Directors. Ms. Bohlen is the chief operating officer of the Archdiocese of Chicago, where she... Read more

Maine farmers will soon have access to an estimated 15,000,000 organic, feminized high-CBD hemp seeds from Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF). After initial setbacks due to the discovery of ledge at its leased farm in Hersey, Maine and seed delivery delays,... Read more

Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market, is pleased to announce that it has signed an agreement to conduct a three month paid pilot of its iUGO Care remote... Read more

INSYS Therapeutics, Inc. (INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that it has reached an agreement in principle with the Department of Justice (DOJ) to settle the DOJ’s civil and criminal investigation into inappropriate sales and commercial practices by... Read more